Black Fungus (Mucormycosis) is a rare but serious fungal infection caused by environmental molds, often affecting people with weakened immunity. When it involves the eyes (rhino-orbital mucormycosis), it can cause symptoms like eye swelling, pain, vision loss, and may spread rapidly if not treated early.

Most people in India had never heard of mucormycosis before 2021. Then the second COVID-19 wave arrived, and almost overnight the term black fungus was everywhere. Hospital wards that had just managed the peak of COVID admissions found themselves dealing with a new emergency, one that ophthalmologists, ENT surgeons, and neurosurgeons had to handle together, often at speed.
Mucormycosis is caused by a group of moulds called mucormycetes. These fungi are genuinely common in the environment, turning up in soil, in compost, in the dust we breathe every day. For a person with a healthy immune system, exposure is not a problem. The body deals with inhaled spores routinely and without any symptoms. The danger arises when immunity is significantly compromised. In that situation, the fungus can take hold in the sinuses, spread into the eye socket, and in severe cases push into the brain, all within days.
The “black” in the common name refers to the dead, darkened tissue the infection leaves behind, which is visible during a nasal examination in affected patients. Medically, the form that concerns eye specialists most is rhino-orbital-cerebral mucormycosis, or ROCM, which travels from the nasal cavity into the orbit and beyond.
India’s experience with mucormycosis during the pandemic was unlike anything seen elsewhere in the world. Between April and June 2021, the Indian Council of Medical Research recorded somewhere between 40,000 and 50,000 cases nationally. To put that in perspective, mucormycosis was previously considered a rare disease even in high-risk populations.
Several factors converged to produce this surge. Corticosteroids, which were widely used to manage the severe lung inflammation of COVID-19, suppress immune function and push blood glucose levels up sharply. Poorly controlled diabetes, which is already extremely prevalent in India, created fertile ground for fungal growth. Some reports also pointed to the use of contaminated or non-humidified oxygen delivery systems in overwhelmed hospitals.
The rhino-orbital-cerebral form dominated the Indian case series. It begins quietly, with what might seem like a blocked nose or mild facial pain, and then escalated fast. Orbital involvement produces swelling around the eye, a protruding eyeball, drooping of the eyelid, and loss of eye movement. Vision can deteriorate within hours.
| Type | Structures Affected | Eye-Related Symptoms |
|---|---|---|
| Rhino-Orbital Mucormycosis | Nose, sinuses, orbit | Orbital swelling, proptosis, reduced vision |
| Rhino-Orbital-Cerebral (ROCM) | Nose, sinuses, orbit, brain | Severe vision loss, fixed dilated pupil, cranial nerve palsy |
| Orbital Apex Syndrome | Posterior orbit, optic nerve | Sudden blindness, pain, restricted eye movement |
Diagnosing mucormycosis quickly is one of the harder challenges in medicine because early symptoms overlap with far more common conditions. A blocked nose and mild facial discomfort could be sinusitis. Only when the eye becomes involved does the picture become clearer, and by that point the infection has already progressed.
Diagnosis is confirmed through a combination of clinical examination, imaging, and laboratory work. An ophthalmologist looks for proptosis, chemosis (swelling of the conjunctiva), ptosis, loss of eye movement, and changes to vision and pupil response. An ENT specialist examines the nasal passages for the blackened necrotic tissue that gives the disease its common name. MRI or CT imaging of the orbit, sinuses, and brain maps how far the infection has spread. Biopsy of affected tissue confirms the specific organism under microscopy and culture.
Treatment has two tracks running simultaneously. Antifungal therapy with intravenous liposomal amphotericin B is started as soon as the diagnosis is clinically suspected, without waiting for laboratory confirmation, because delay costs patients their vision and sometimes their lives. Surgical debridement removes the infected and dead tissue. In cases where the orbit is extensively involved and the infection cannot otherwise be controlled, orbital exenteration (removal of the eye and surrounding orbital contents) becomes necessary as a life-saving measure, not an outcome anyone wants, but sometimes the only way to stop the fungus from reaching the brain.
Anyone with diabetes, a recent COVID-19 infection, organ transplantation, blood cancer, or long-term steroid use should know these warning signs. This is not a condition where a wait-and-see approach is safe:
Every one of these symptoms in a high-risk individual is a medical emergency. Go to the hospital. Do not wait for a routine appointment.
Mucormycosis treatment is among the more expensive medical episodes a patient can face, largely because of the cost of liposomal amphotericin B and the length of hospitalisation required:
| Component | Approximate Cost Range (INR) |
|---|---|
| Hospitalisation (per day) | ₹3,000 – ₹15,000 |
| Liposomal Amphotericin B (full course) | ₹1,00,000 – ₹5,00,000 |
| Surgical debridement (endoscopic) | ₹50,000 – ₹1,50,000 |
| Orbital exenteration (if required) | ₹80,000 – ₹2,00,000 |
| Total (typical range) | ₹3,00,000 – ₹10,00,000+ |
Costs vary considerably based on severity, duration of treatment, and hospital type. Government hospitals may provide subsidised treatment. Financial assistance schemes were made available during the 2021 surge and may be accessible in future outbreaks.
Recovery from mucormycosis is a long road. Unlike most infections that resolve over a week or two, this one demands months of sustained effort from both the medical team and the patient. How well someone recovers depends enormously on how early the diagnosis was made, how completely the infected tissue was removed, and whether the underlying risk factors have been brought under control.
Patients whose optic nerve was damaged before treatment reached them may have permanent vision loss. Those who required orbital exenteration will need a facial prosthesis fitted and, just as importantly, will need psychological support to process what has happened. The physical recovery is only part of it.
Oral antifungal medication continues for months after discharge, and regular MRI imaging is used to confirm that the infection has truly resolved rather than merely quietened down.
WebMD. Mucormycosis (Black Fungus Infection). https://www.webmd.com/lung/mucormycosis-black-fungus-infection
Pace Hospital. Mucormycosis: Causes, Symptoms, Diagnosis and Treatment. https://www.pacehospital.com/black-fungus-infection-mucormycosis-disease-causes-symptoms-diagnosis-and-treatment
No. Mucormycosis does not pass from one person to another. The fungus lives in soil and decaying organic matter and is inhaled as spores. Infection only takes hold when the immune system is too compromised to clear those spores naturally.
The short answer is corticosteroids combined with diabetes. High-dose steroids were used widely to manage severe COVID-19 pneumonia, and they suppress immune function while driving blood sugar up sharply. In a country where diabetes is already extremely common and often poorly controlled, that combination created conditions the fungus could exploit on a massive scale.
Sometimes, yes. If the infection is caught early and treated aggressively before the optic nerve is irreversibly damaged, vision can be preserved. Once significant optic nerve damage has occurred, vision loss tends to be permanent. The window for intervention is narrow, which is why these cases are treated as emergencies.
Orbital exenteration means removing the eye and all the contents of the eye socket, including muscles, fat, and sometimes the eyelids. It is a drastic procedure and nobody recommends it lightly. It is done when the infection has spread so widely through the orbit that no other approach can stop it from reaching the brain. The goal is to save the patient’s life, even at the cost of the eye.
Yes. Recurrence is a real risk if the underlying vulnerability has not been addressed. A diabetic patient who leaves hospital with poorly controlled blood sugar is at risk again. This is why the oral antifungal course continues for months and why follow-up monitoring continues long after the acute phase is over.
People with uncontrolled diabetes mellitus are the largest at-risk group in India. Others at significant risk include organ and stem cell transplant recipients, patients on long-term steroid or immunosuppressive therapy, and those with blood cancers such as leukaemia or lymphoma.
It is available, though the supply can be variable outside major cities and it is expensive. During the 2021 outbreak the Government of India stepped in to procure and distribute the drug at subsidised rates. Availability in future outbreaks would depend on government response and hospital procurement.
Intravenous antifungal therapy typically runs for three to eight weeks. Oral antifungal treatment then continues for several more months. Multiple surgical procedures for debridement may be needed. All told, treatment from initial hospitalisation to the end of the oral course can span three to twelve months depending on how severe the infection was.
For high-risk individuals, several steps reduce the odds: keeping blood glucose well controlled, using steroids only when genuinely needed and at the lowest effective dose, practising good nasal and oral hygiene, and avoiding high-spore environments like construction sites and areas of heavy organic decomposition. None of these guarantees prevention, but they reduce the window the fungus needs.
The ophthalmologist is central to the team rather than a peripheral contributor. They track proptosis, monitor vision and pupil function, assess the optic nerve, check for retinal artery involvement, and manage corneal exposure if the eyelids are affected. They also help guide decisions about orbital surgery and lead the rehabilitation process for patients who lose an eye.
[FAQ section ends here]
References
WebMD. Mucormycosis (Black Fungus Infection). https://www.webmd.com/lung/mucormycosis-black-fungus-infection
Pace Hospital. Mucormycosis: Causes, Symptoms, Diagnosis and Treatment. https://www.pacehospital.com/black-fungus-infection-mucormycosis-disease-causes-symptoms-diagnosis-and-treatment